RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
class II, major histocompatibility complex, transactivator
This gene encodes a protein with an acidic transcriptional activation domain, 4 LRRs (leucine-rich repeats) and a GTP binding domain. The protein is located in the nucleus and acts as a positive regulator of class II major histocompatibility complex gene transcription, and is referred to as the "master control factor" for the expression of these genes. The protein also binds GTP and uses GTP binding to facilitate its own transport into the nucleus. Once in the nucleus it does not bind DNA but rather uses an intrinsic acetyltransferase (AT) activity to act in a coactivator-like fashion. Mutations in this gene have been associated ...
|
|
|
||
|---|---|---|---|
| Mesenteric lymph nod… |
100
|
||
| Superior surface of … |
87
|
||
| Hemisphere of cerebe… |
85
|
||
| Vermis of cerebellum |
81
|
||
| Set of pancreatic is… |
78
|
||
| Pylorus |
75
|
|
|
|
||
|---|---|---|---|
| Pralidoxime Chloride |
100
|
||
| 2-deoxyglucose |
87
|
||
| Pronethalol |
87
|
||
| Dimethylnitrosamine |
79
|
||
| Methylglyoxal |
68
|
||
| Zoxazolamine |
66
|
Individual Studies |
|
|---|---|
|
|
Authors: Kenneth L Wright, Jenny P-Y Ting
Trends in immunology 2006 SepAuthors: Zuyao Ni, Mohamed Abou El Hassan, Zhaodong Xu, Tao Yu, Rod Bremner
Nature immunology 2008 JulThought leaders and organizations working on research involving CIITA.
conditions: Lymphoma
interventions: belinostat